Patent Assignment
Reel/Frame 054409/0200
Change of Name
Recorded: 2020-11-13
Pages: 2
Assignor
NOVOGEN LIMITED
Executed: 2017-11-16
Assignee
KAZIA THERAPEUTICS LIMITED
THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO AVENUE, SYDNEY, NSW 2000, AUSTRALIA
Covered Properties
(2)
Tricyclic PI3K Inhibitor Compounds and Methods of Use
Tricyclic P13K Inhibitor Compounds and Methods of Use
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 21, 2012
From: DOTSON, JENNAFER; HEFFRON, TIMOTHY; NDUBAKU, CHUDI; OLIVERO, ALAN G.
To: GENENTECH, INC.
Reel/Frame 028243/0062 →
Assignment of Assignor's Interest
May 21, 2012
From: HEALD, ROBERT A.; JONES, GRAHAM E.; KRINTEL, SUSSIE L.; MCLEAN, NEVILLE J.
To: ARGENTA DISCOVERY 2009 LIMITED
Reel/Frame 028243/0198 →
Assignment of Assignor's Interest
May 21, 2012
From: ARGENTA DISCOVERY 2009 LIMITED
To: GENENTECH, INC.
Reel/Frame 028243/0255 →
Assignment of Assignor's Interest
Jun 15, 2012
From: GENENTECH, INC.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 028382/0857 →
Assignment of Assignor's Interest
Aug 31, 2016
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 039602/0394 →
License
Nov 13, 2020
From: GENENTECH, INC.
To: NOVOGEN LIMITED
Reel/Frame 054402/0865 →